derived – cannabis.co.nz

July 7, 2022additive, analysis, analytics, business, Business Analysis, cannabidiol, cannabis, cbd, compliance, consumer, data, derived, dietary, drug, Edibles & Processing, EFSA, EU, europe, extraction, FDA, Federal, food, Gendel Food Safety, government, gras, growing, hemp, industry, international, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, New, novel, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, review, safety, state, Steven Gendel, test, Testing, thc, US

CBD Safety in Edibles: What Regulators are Thinking

Despite the popularity of cannabidiol (CBD) infused edibles among consumers there are storm clouds on the horizon for this market. The potential […]

September 16, 2021analysis, analytics, business, Business Analysis, cannabinoid, cannabis, cbd, compliance, consumer, consumer update, Delta, delta 8, Delta 9, derived, extraction, FDA, Federal, government, growing, hemp, industry, law, legal, legalization, legalize, legislation, license, marijuana, market, processing, product, Product Development, production, psychoactive, Quality, recreational, regulation, regulations, regulatory, retail, safety, state, synthesize, synthetic, test, Testing, thc, warning

FDA Issues Warnings on Delta-8 THC Products

On September 14, the FDA published a consumer update on their website, seeking to educate the public and offer a public health […]

May 18, 20219, analysis, analytics, business, cannabis, cbd, compliance, consumer, Delta, delta 8, delta-8-tetrahydrocannabinol, delta-9 tetrahydrocannabinol, DeltaVera, derived, disc, dispensary, Edibles & Processing, Federal, government, growing, gummies, gummy, hemp, industry, law, legal, legality, legalization, legalize, legislation, marijuana, market, medical, medicine, PK Isacs, product, Product Development, products, Quality, recreational, regulation, regulations, regulatory, retail, safety, Sam Andrus, state, test, Testing, thc

The New Delta 8 THC Market: A Q&A with the Founders of DeltaVera

Delta 8 THC (delta-8-tetrahydrocannabinol) sprung onto the scene late last year in a big way. While similar to the much more widely-known […]

April 23, 2021analysis, analytics, business, Business Analysis, CANADA, canadian, cannabis, cbd, Charlotte's Web, compliance, cultivar, cultivation, Cultivation & Growing, derived, expansion, Federal, full spectrum, government, growing, growth, Health Canada, hemp, holdings, industrial, industry, international, law, legal, legalization, legalize, legislation, license, marijuana, market, product, Product Development, products, proprietary, Quality, regulations, regulatory, strain, strategy, thc

Charlotte’s Web Poised for Canadian Expansion

Charlotte’s Web Holdings, the company that just about launched the entire CBD industry, announced this week that they have just been approved […]

January 28, 2021absorb, analysis, analytics, beverage, bioavailability, bioavailable, blood, bloodstream, business, cannabidiol, cannabinoid, cannabinoids, cannabis, cbd, delivery, derived, development, drink, Edibles & Processing, emulsion, extraction, growing, hemo, hemp, HEXO, industry, infuse, infused, joint, legalization, legalize, line, marijuana, market, Molson Coors, nano, nanoemulsion, offering, product, Product Development, Quality, Quicksilver, research, retail, safety, scientific, solubility, soluble, stream, tech, Technology, Truss, USA, venture, Veryvell

Molson Coors Joint Venture Selects Quicksilver Scientific as Technology Partner

According to a press release published this week, Quicksilver Scientific, a nanoemulsion delivery technology company, announced a partnership with Truss CBD USA, […]

October 28, 20201, analysis, analytics, and Cosmetics Act, application, approval, approve, business, Business Analysis, cannabidiol, cannabis, cbd, clinical, clinical trials, compliance, consumer packaged goods, CPG, CSA, dea, derived, deschedule, descheduled, Dravet syndrome, drug, Drug Enforcement Administration, Epidiolex, epilepsy, extraction, FDA, FDCA, Federal, Federal Food, FFDCA, food and drug administration, formulation, government, GW, GW Pharma, hemp, industry, law, legal, legalization, legalize, legislation, Lennox-Gastaut syndrome, license, marijuana, market, medical, medicine, New, patent, pathway, patient, pharma, pharmaceutical, product, Product Development, program, regulation, regulations, regulatory, REMS, safety, schedule, seizures, state, Substances, thc, trial, TSC

How GW Pharma Won CBD

As of this writing, the United States Food and Drug Administration (FDA) has approved GW Pharma’s CBD drug Epidiolex for treating profound […]

October 27, 2020analysis, analytics, audit, branding, business, Business Analysis, cannabidiol, cannabis, cbd, certificate, certification, chain, COA, compliance, Concentrates & Extracts, contract, credibility, cultivation, demographic, derived, differentiate, Dispensaries & Retail, Edibles & Processing, extraction, Federal, GFSI, Global Food Safety Initiative, government, growing, hemp, industry, label, labeling, labelling, law, legal, legalization, legalize, legislation, license, manufacturing, marijuana, market, marketing, organic, party, private, product, Product Development, program, Quality, recreational, regulation, regulatory, retail, Safe Quality Food, safety, seal, SQF, state, supply, test, third, third-party, transparency, USDA, white

Overcoming Challenges in the Private Label CBD Industry

Private labelling, or white labelling, is a popular option for brands looking to enter the CBD space. This practice is where a […]

October 23, 20200.3, 2018, affairs, Agricultural Improvement Act, analysis, analytics, ban, bill, business, Business Analysis, california, cannabidiol, cannabis, cbd, committee, compliance, consumer, court, cultivation, derived, enact, extraction, farm, farm bill, Federal, florida, Georgia, government, growing, Hawaii, hemp, hemp-derived, house, illinois, Indiana, Iowa, kansas, law, Laws, lawsuit, legal, legality, legalization, legislation, license, Louisiana, marijuana, market, massachusetts, michigan, mississippi, new jersey, new york, of appeals, producer, product, Quality, regulating, regulation, regulations, regulatory, retail, safety, senate, state, test, Testing, Texas, thc, Utah, washington

A Survey of State CBD & Hemp Regulation Since The 2018 Farm Bill

Since the December 20, 2018 enactment of the Agricultural Improvement Act of 2018, better known as the Farm Bill, we have seen […]

September 24, 2020%, 0.3, 2018, analysis, analytics, business, Business Analysis, cannabidiol, cannabis, cbd, compliance, Concentrates & Extracts, consumer, controlled, cultivation, dea, derived, Drug Enforcement Administration, Edibles & Processing, extraction, farm bill, Federal, final, government, growing, hemp, industry, interim, justice department, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, limit, marihuana, marijuana, market, product, Product Development, Quality, regulation, regulations, regulatory, rule, rulemaking, schedule, state, substance, test, Testing, thc

The DEA’s Interim Final Rule and its Impact on the Industrial Hemp Industry

On August 20, 2020, the Drug Enforcement Administration (DEA) published an Interim Final Rule on industrial hemp and hemp derivatives (the interim […]

September 10, 2020analysis, analytics, business, Business Analysis, cannabidiol, cannabis, cbd, compliance, Congress, congressional, controlled substances act, cultivation, dea, department of justice, derived, DOJ, Drug Enforcement Administration, farm, Farming, FDA, FDCA, Federal, food and drug administration, government, growing, hemp, industry, interim, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, National Institute of Standards and Technology, NIST, plant, plants, political, politics, product, Quality, recreational, reg, regulation, regulations, regulatory, retail, rule, safety, schedule, state, test, Testing, thc, THCA

CBD Industry Caught Between Regulators & Law Enforcement

The consumer-facing CBD industry operates in a regulatory gray zone even as it grows in prominence. Illegal to market as an unapproved […]